Overview

CA19-9


Related Overviews

 

'CA19-9' can also refer to...

CA19-9

CA19-9 n.

The prognostic and predictive value of serum CA19.9 in pancreatic cancer

Tumor Markers CEA, CA19-9 and CA125 in Monitoring of Response to Systemic Chemotherapy in Patients with Advanced Gastric Cancer

P-024Carcinoembryonic antigen (CEA) and the carcinoma antigen 19-9 (CA 19-9) together in early diagnosis of Stage I-II colorectal adenocarcinoma. A case-control study

P-035Simultaneous carcinoembryonic antigen (CEA), carcinoma antigen 19-9 (CA 19-9) and 125 (CA-125) measurement in patients with gastric cancer (stage IA-IB): a case-control study

P-0128PROGNOSTIC SIGNIFICANCE OF CEA, CA19-9 AND CA72-4 SERUM LEVEL BEFORE AND AFTER PREOPERATIVE CHEMOTHERAPY OF ESOPHAGOGASTRIC JUNCTION ADENOCARCINOMA

Significance of Serum Concentrations of E-selectin and CA19-9 in the Prognosis of Colorectal Cancer

Persistent Elevation of CA 19-9 in an Apparently-Healthy 56-Year-Old Woman

P-0074INVESTIGATION OF VALUE OF CARCINOEMBRYONIC ANTIGEN (CEA) AND CARBOHYDRATE ANTIGEN (CA) 19.9 IN THE DIAGNOSIS OF GASTRIC CANCER

P-0199THE PROGNOSTIC VALUE OF PREOPERATIVE SERUM CEA AND CA19-9 VALUES IN STAGE I ∼ III COLORECTAL CANCER

P-119Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma

P-166Decrement of Serum CA 19-9 Concentration after Initial Chemotherapy Predicts Favorable Outcome in Patients with Advanced Pancreatic Cancer

P-048Prognostic Impact of CA19-9 Level at Diagnosis in Resected Stage I-III Pancreatic Adenocarcinoma: a US Population Study

169PSerum CA19-9 response is an early predictive marker for the efficacy of regorafenib in refractory metastatic colorectal cancer

PD-0022DECLINE IN CA19-9 DURING CHEMOTHERAPY PREDICTS SURVIVAL IN FOUR INDEPENDENT COHORTS OF PATIENTS WITH INOPERABLE CHOLANGIOCARCINOMA.

P-0114CA 19-9 RELATED TUMOR GROWTH RATE AFTER FIRST LINE CHEMOTHERAPY OF ADVANCED PANCREATIC CANCER

Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions

PD-0020CA19-9 DECREASE AND KINETICS IN A RANDOMIZED PHASE III TRIAL (MPACT) OF WEEKLY NAB-PACLITAXEL PLUS GEMCITABINE IN METASTATIC PANCREATIC CANCER

 

More Like This

Show all results sharing this subject:

  • Medicine and Health

GO

Show Summary Details

Quick Reference

n. a substance whose presence in the bloodstream can be increased in certain cancers, such as pancreatic cancers, and is increasingly used as a tumour marker in blood tests.

Subjects: Medicine and Health.


Reference entries

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.